Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C.

<h4>Background and aim</h4>To evaluate in anti-HCV-positive patients the clinical impact of the rs35761398 variant of the CNR2 gene leading to the substitution of Gln (Q) of codon 63 of the cannabinoid receptor 2 (CB2) with Arg (R).<h4>Patients and methods</h4>253 consecutive...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nicola Coppola, Rosa Zampino, Caterina Sagnelli, Giulia Bellini, Aldo Marrone, Maria Stanzione, Nicolina Capoluongo, Adriana Boemio, Carmine Minichini, Luigi Elio Adinolfi, Sabatino Maione, Emanuele Miraglia Del Giudice, Evangelista Sagnelli, Francesca Rossi
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/bf55c19cdeb04fd69ae4730ccda770ff
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bf55c19cdeb04fd69ae4730ccda770ff
record_format dspace
spelling oai:doaj.org-article:bf55c19cdeb04fd69ae4730ccda770ff2021-11-18T08:15:09ZCannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C.1932-620310.1371/journal.pone.0099450https://doaj.org/article/bf55c19cdeb04fd69ae4730ccda770ff2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24940753/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background and aim</h4>To evaluate in anti-HCV-positive patients the clinical impact of the rs35761398 variant of the CNR2 gene leading to the substitution of Gln (Q) of codon 63 of the cannabinoid receptor 2 (CB2) with Arg (R).<h4>Patients and methods</h4>253 consecutive anti-HCV-/HCV-RNA-positive patients were enrolled, of whom 53 were HCV carriers with persistently normal ALT (PNALT group) and 200 had a history of steadily abnormal serum ALT values (abnormal ALT group). All patients were naive for antiviral therapy and were screened for the CNR2 rs35761398 polymorphism by a TaqMan assay.<h4>Results</h4>Subjects in the PNALT group, compared with those in the abnormal ALT group were older (58.5±12 vs. 50.7±12.4 years, p = 0.001), more frequently female (66% vs. 42%, p = 0.003), with lower body mass index (BMI) (24.5±3.1 vs. 26.6±4.6, p = 0.003), and more frequently with HCV genotype 2 (43.1% vs 17.7%, p = 0.0002) and CB2-63 QQ variant (34% vs. 11%, p = 0.0001). Considering all 253 patients, no difference in the demographic, biochemical, or virological data was observed between patients in the different CB2-63 variants. The logistic regression analysis identified CB2-63 QQ, HCV genotype 2, older age and lower BMI as independent predictors of PNALT (p<0.00001).<h4>Discussion</h4>The CB2-63 QQ variant in HCV patients was independently associated with the PNALT status.Nicola CoppolaRosa ZampinoCaterina SagnelliGiulia BelliniAldo MarroneMaria StanzioneNicolina CapoluongoAdriana BoemioCarmine MinichiniLuigi Elio AdinolfiSabatino MaioneEmanuele Miraglia Del GiudiceEvangelista SagnelliFrancesca RossiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 6, p e99450 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Nicola Coppola
Rosa Zampino
Caterina Sagnelli
Giulia Bellini
Aldo Marrone
Maria Stanzione
Nicolina Capoluongo
Adriana Boemio
Carmine Minichini
Luigi Elio Adinolfi
Sabatino Maione
Emanuele Miraglia Del Giudice
Evangelista Sagnelli
Francesca Rossi
Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C.
description <h4>Background and aim</h4>To evaluate in anti-HCV-positive patients the clinical impact of the rs35761398 variant of the CNR2 gene leading to the substitution of Gln (Q) of codon 63 of the cannabinoid receptor 2 (CB2) with Arg (R).<h4>Patients and methods</h4>253 consecutive anti-HCV-/HCV-RNA-positive patients were enrolled, of whom 53 were HCV carriers with persistently normal ALT (PNALT group) and 200 had a history of steadily abnormal serum ALT values (abnormal ALT group). All patients were naive for antiviral therapy and were screened for the CNR2 rs35761398 polymorphism by a TaqMan assay.<h4>Results</h4>Subjects in the PNALT group, compared with those in the abnormal ALT group were older (58.5±12 vs. 50.7±12.4 years, p = 0.001), more frequently female (66% vs. 42%, p = 0.003), with lower body mass index (BMI) (24.5±3.1 vs. 26.6±4.6, p = 0.003), and more frequently with HCV genotype 2 (43.1% vs 17.7%, p = 0.0002) and CB2-63 QQ variant (34% vs. 11%, p = 0.0001). Considering all 253 patients, no difference in the demographic, biochemical, or virological data was observed between patients in the different CB2-63 variants. The logistic regression analysis identified CB2-63 QQ, HCV genotype 2, older age and lower BMI as independent predictors of PNALT (p<0.00001).<h4>Discussion</h4>The CB2-63 QQ variant in HCV patients was independently associated with the PNALT status.
format article
author Nicola Coppola
Rosa Zampino
Caterina Sagnelli
Giulia Bellini
Aldo Marrone
Maria Stanzione
Nicolina Capoluongo
Adriana Boemio
Carmine Minichini
Luigi Elio Adinolfi
Sabatino Maione
Emanuele Miraglia Del Giudice
Evangelista Sagnelli
Francesca Rossi
author_facet Nicola Coppola
Rosa Zampino
Caterina Sagnelli
Giulia Bellini
Aldo Marrone
Maria Stanzione
Nicolina Capoluongo
Adriana Boemio
Carmine Minichini
Luigi Elio Adinolfi
Sabatino Maione
Emanuele Miraglia Del Giudice
Evangelista Sagnelli
Francesca Rossi
author_sort Nicola Coppola
title Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C.
title_short Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C.
title_full Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C.
title_fullStr Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C.
title_full_unstemmed Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C.
title_sort cannabinoid receptor 2-63 qq variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis c.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/bf55c19cdeb04fd69ae4730ccda770ff
work_keys_str_mv AT nicolacoppola cannabinoidreceptor263qqvariantisassociatedwithpersistentlynormalaminotransferaseserumlevelsinchronichepatitisc
AT rosazampino cannabinoidreceptor263qqvariantisassociatedwithpersistentlynormalaminotransferaseserumlevelsinchronichepatitisc
AT caterinasagnelli cannabinoidreceptor263qqvariantisassociatedwithpersistentlynormalaminotransferaseserumlevelsinchronichepatitisc
AT giuliabellini cannabinoidreceptor263qqvariantisassociatedwithpersistentlynormalaminotransferaseserumlevelsinchronichepatitisc
AT aldomarrone cannabinoidreceptor263qqvariantisassociatedwithpersistentlynormalaminotransferaseserumlevelsinchronichepatitisc
AT mariastanzione cannabinoidreceptor263qqvariantisassociatedwithpersistentlynormalaminotransferaseserumlevelsinchronichepatitisc
AT nicolinacapoluongo cannabinoidreceptor263qqvariantisassociatedwithpersistentlynormalaminotransferaseserumlevelsinchronichepatitisc
AT adrianaboemio cannabinoidreceptor263qqvariantisassociatedwithpersistentlynormalaminotransferaseserumlevelsinchronichepatitisc
AT carmineminichini cannabinoidreceptor263qqvariantisassociatedwithpersistentlynormalaminotransferaseserumlevelsinchronichepatitisc
AT luigielioadinolfi cannabinoidreceptor263qqvariantisassociatedwithpersistentlynormalaminotransferaseserumlevelsinchronichepatitisc
AT sabatinomaione cannabinoidreceptor263qqvariantisassociatedwithpersistentlynormalaminotransferaseserumlevelsinchronichepatitisc
AT emanuelemiragliadelgiudice cannabinoidreceptor263qqvariantisassociatedwithpersistentlynormalaminotransferaseserumlevelsinchronichepatitisc
AT evangelistasagnelli cannabinoidreceptor263qqvariantisassociatedwithpersistentlynormalaminotransferaseserumlevelsinchronichepatitisc
AT francescarossi cannabinoidreceptor263qqvariantisassociatedwithpersistentlynormalaminotransferaseserumlevelsinchronichepatitisc
_version_ 1718422008851595264